Structural Heart Devices Market to Reach USD 30.62 Billion by 2034 at 10.08% CAGR | DelveInsight

DelveInsight's "Structural Heart Devices Market Insights and Market Forecast" report delivers an in-depth understanding of the Structural Heart Devices market by Product Type, Application, End-User, and Geography, covering North America, Europe, Asia-Pacific, and Rest of World.

Explore the intricate details of the Structural Heart Devices Market Report @ https://www.delveinsight.com/report-store/structural-heart-devices-market-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=akpr

Key Takeaways from Structural Heart Devices Market Report
• In May 2026, Artivion, Inc., the parent company of JOTEC GmbH, completed its acquisition of Endospan Ltd. for an upfront net purchase price of USD 135 million, adding the NEXUS Aortic Arch System to its structural and aortic repair portfolio.
• In February 2026, Valcare Medical, Inc., announced the successful first U.S. transseptal implantation of its AMEND Transcatheter Mitral Valve Repair Annuloplasty System as part of its ongoing Early Feasibility Study.
• In January 2026, XELTIS BV published early clinical outcomes from two trials of its restorative pulmonary valve conduit, showing sustained functionality as the bioabsorbable polymer scaffold is colonized by the patient's own tissue.
• The Structural Heart Devices market is estimated at USD 12.94 billion in 2025 and is projected to reach USD 30.62 billion by 2034, growing at a CAGR of 10.08% from 2026 to 2034.
• North America dominated the global market with a 50% revenue share in 2025, the highest of any region, while Asia-Pacific is the fastest-growing region.
• Aortic valve stenosis affects an estimated 9 million people worldwide, while mitral regurgitation affects nearly 24 million people globally.
• Congenital heart defects affect nearly 1% of all births in the United States, roughly 40,000 babies each year, with about one in four requiring immediate intervention.
• More than 5 million people are diagnosed with heart valve disease annually in the United States, with over 25,000 associated deaths.
• In the United Kingdom, heart valve disease affects 11.29% of individuals aged 65 and older.
• In Australia, more than 500,000 individuals were diagnosed with heart valve disease in 2024, with an additional estimated 250,000 cases remaining undiagnosed.

Get a Free sample for the Structural Heart Devices Market Forecast, Size & Share Analysis Report @ https://www.delveinsight.com/sample-request/structural-heart-devices-market-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=akpr

What is a Structural Heart Device?
A structural heart device is a specialized medical technology designed to diagnose, repair, or replace abnormalities in the heart's structure, including its valves, chambers, walls, and associated vessels. Structural heart disease encompasses both congenital defects, such as atrial septal defect, ventricular septal defect, and patent foramen ovale, and acquired valvular disorders, such as aortic valve stenosis and mitral regurgitation. Treatment increasingly relies on catheter-based repair devices, including occluders, annuloplasty devices, and valvuloplasty devices, alongside surgical and transcatheter replacement devices, including mechanical and tissue heart valves. These technologies offer minimally invasive alternatives to open-heart surgery, reducing surgical trauma, shortening hospital stays, and expanding treatment access to elderly and high-risk patients who are often poor candidates for conventional surgery.

Structural Heart Devices Market Segmentation
• By Product Type: Repair Device (Occluders, Annuloplasty Devices, Valvuloplasty Devices, and Others) and Replacement Device (Mechanical Heart Valves and Tissue Heart Valves)
• By Application: Atrial Septal Defect, Aortic Valve Stenosis, Patent Foramen Ovale, Ventricular Septal Defects, Mitral Regurgitation, and Others
• By End-User: Hospital, Ambulatory Surgical Centers, and Others
• By Geography: North America, Europe, Asia-Pacific, and Rest of World

Download the report to understand which factors are driving Structural Heart Devices market trends @ https://www.delveinsight.com/report-store/structural-heart-devices-market-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=akpr

Structural Heart Devices Market Key Growth Drivers
• The rising global prevalence of cardiovascular and valvular disorders, including aortic stenosis, mitral regurgitation, and congenital heart defects, is expanding the patient pool eligible for structural heart interventions.
• Continuous technological advancement, including next-generation transcatheter heart valves, minimally invasive mitral and tricuspid repair systems, and improved annuloplasty platforms, is broadening eligible patient anatomies and improving procedural outcomes.
• Growing demand for minimally invasive cardiac interventions is accelerating adoption, as catheter-based procedures offer reduced surgical trauma, shorter hospital stays, and faster recovery relative to open-heart surgery.
• Regulatory approvals and label expansions, including Edwards Lifesciences' April 2025 CE Mark for the SAPIEN M3 transcatheter mitral valve replacement system and Abbott's continued TriClip clinical evidence generation, are widening the treatable patient population.
• Heavy capital investment and active M&A activity, including Boston Scientific's acquisition of Baylis Medical and Artivion's 2026 acquisition of Endospan, are expanding structural heart device portfolios and manufacturing capacity.
• An aging global population and rising rates of hypertension, obesity, and diabetes are increasing the incidence of degenerative valvular disease, sustaining long-term structural heart device demand through 2034.

Structural Heart Devices Market Restraints
Frequent product failures and recalls undermine physician confidence and disrupt treatment adoption. Stringent regulatory requirements, including extensive clinical trials and long evaluation timelines, slow innovation and create barriers to entry for new players. The high capital intensity of developing and manufacturing transcatheter platforms, combined with the need for specialized hybrid operating rooms and highly trained interventional cardiologists, constrains adoption in emerging economies. Reimbursement variability and tariffs on imported medical devices and components further temper near-term growth.

Structural Heart Devices Market Companies
Medtronic, Boston Scientific Corporation, Braile Biomedica, JOTEC GmbH, Edwards Life Sciences Corporation, Valcare Medical, W. L. Gore & Associates, Inc., Abbott Laboratories, Cardiovascular Systems, Inc., XELTIS BV, and others

Discover more about companies competing for major Structural Heart Devices market share @ https://www.delveinsight.com/sample-request/structural-heart-devices-market-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=akpr

Structural Heart Devices Market Outlook
The Structural Heart Devices market is classified as moderately consolidated, anchored by global leaders with broad product portfolios and deep clinical evidence, including Medtronic, Edwards Lifesciences, Abbott, and Boston Scientific, alongside specialized and fast-scaling providers such as Valcare Medical, XELTIS BV, JOTEC GmbH, Braile Biomedica, W. L. Gore & Associates, and Cardiovascular Systems. Replacement devices, spanning surgical and transcatheter mechanical and tissue heart valves, lead the product landscape as TAVR becomes standard care across high-risk, intermediate-risk, and increasingly low-risk patients. Atrial septal defect repair leads by application on the back of rising minimally invasive occluder adoption, while hospitals remain the dominant end-user given the advanced infrastructure structural heart procedures require. North America leads regionally on the strength of its interventional cardiology ecosystem and regulatory clarity, while Asia-Pacific is the fastest-growing region as infrastructure and healthcare investment expand across China, Japan, India, South Korea, and Australia.

Scope of the Structural Heart Devices Market Report
• Market Size (2025): USD 12.94 billion
• Projected Market Size (2034): USD 30.62 billion
• Growth Rate (2026-2034): 10.08% CAGR
• Largest Market: North America
• Fastest Growing Market: Asia-Pacific
• Market Structure: Moderately Consolidated
• Structural Heart Devices Companies: Medtronic, Boston Scientific Corporation, Braile Biomedica, JOTEC GmbH, Edwards Life Sciences Corporation, Valcare Medical, W. L. Gore & Associates, Inc., Abbott Laboratories, Cardiovascular Systems, Inc., XELTIS BV, and others
• Structural Heart Devices Market Segments: Product Type, Application, End-User, and Geography
• Structural Heart Devices Market Dynamics: Structural Heart Devices market drivers and market restraints
• Competitive Intelligence Analysis: Market concentration, leading players, geographic reach, service portfolio strength, clinical evidence, strategic partnerships, M&A activity, manufacturing capabilities, and innovation focus

To know more about companies working in the Structural Heart Devices market, visit @ https://www.delveinsight.com/sample-request/structural-heart-devices-market-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=akpr

Table of Contents
1. Structural Heart Devices Market Report Introduction
2. Structural Heart Devices Market Executive Summary
3. Structural Heart Devices Market Key Factors Analysis
4. Impact Analysis: AI, Geopolitical, Trade, and Economic Developments
5. Regulatory Analysis
6. Structural Heart Devices Market Porter's Five Forces Analysis
7. Structural Heart Devices Market Assessment
8. Structural Heart Devices Market Competitive Landscape
9. Structural Heart Devices Market Startup Funding and Investment Trends
10. Structural Heart Devices Market Company and Product Profiles
11. KOL Views
12. Project Approach
13. About DelveInsight
14. Disclaimer and Contact Us

Company Name: DelveInsight Business Research LLP
Contact Person: Abhishek kumar
Email: info@delveinsight.com
Phone: 9650213330
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com

About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

This release was published on openPR.